A key feature of tumour immune evasion is the increased expression of certain ligands, notably programmed cell death-ligand 1 (PD-L1), at the cell surface of cancer cells and immune cells, such as dendritic cells and macrophages [200,201]. This evidence concerns the gene CD274 and cancer.